The program features discussions on preparing the bioscience company for institutional investors, structuring venture capital transactions, follow on financing transactions, and exit strategies for the bioscience company. Panelists include Scott Cousino of Legg Mason, Rene Salas of Ernst & Young, William Snider of Emerging Technology Partners, and Venable's Michael Schlesinger.
Suggested audience for the series includes: CEOs, COOs, CFOs, CSOs, general counsel, research directors, investors and business development and technology professionals.
Additionally, the following seminars have been scheduled:
For additional information about the series or to receive registration information, please contact Ruth Kaufman via e-mail at email@example.com or at (202) 216-8595. Also, please check www.venable.com for updates.
In the event of inclement weather, a scheduled Venable seminar or event will be postponed and re-scheduled if the federal government is closed for the day.
One of the American Lawyer’s top 100 law firms, Venable LLP has attorneys practicing in all areas of corporate and business law, complex litigation, intellectual property and government affairs. Venable serves corporate, institutional, governmental, nonprofit and individual clients throughout the U.S. and around the world from its headquarters in Washington, D.C. and offices in California, Maryland, New York and Virginia. For more, visit www.Venable.com.